Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis
2024 · ACS Nano · 26 citations
https://doi.org/10.1021/acsnano.4c03034
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
18
Papers
118
Citations
6
h-index
3
i10-index
Jingting Wang is an academic researcher from Nanjing Agricultural University. The author has contributed to research in topics: Lung Cancer Diagnosis and Treatment & Immunotherapy and Immune Responses & Nanoplatforms for cancer theranostics. The author has an h-index of 6, co-authored 16 publications.
ORCID: 0000-0002-9245-280XClick to start Chat